Neo Ivy Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$947K	Sell	23,505 -328	-1%	-$12.3K	0.25%	143
2025 Q4	$829K	Buy	+23,833	New	+$1.87M	0.13%	182
2025 Q3	–	Sell	-1,419	Closed	-$104K	–	411
2025 Q2	$104K	Sell	1,419 -5,553	-80%	-$403K	0.03%	292
2025 Q1	$796K	Buy	+6,972	New	+$424K	0.25%	130
2023 Q4	–	Sell	-2,424	Closed	-$66K	–	318
2023 Q3	$66K	Sell	2,424 -2,178	-47%	-$63K	0.03%	270
2023 Q2	$102K	Buy	+4,602	New	+$106K	0.05%	237
2022 Q4	$453K	Buy	22,314 +22,255	+37,720%	+$558K	0.31%	166
2022 Q3	$2K	Buy	+59	New	+$1.58K	0.01%	357
2022 Q2	–	Sell	-4,980	Closed	-$112K	–	439
2022 Q1	$112K	Buy	+4,980	New	+$106K	0.1%	289
2021 Q3	–	Sell	-1,529	Closed	-$34K	–	494
2021 Q2	$34K	Sell	1,529 -11,890	-89%	-$265K	0.03%	346
2021 Q1	$319K	Buy	+13,419	New	+$358K	0.35%	99
2020 Q4	–	Sell	-510	Closed	-$8K	–	441
2020 Q3	$8K	Buy	+510	New	+$8.13K	0.01%	431